AMD Slides, SpaceX Falls, Eli Lilly Jumps as Obesity Drug Boom Shows No Sign of Slowing

On this episode of Stock Movers: 

• Advanced Micro Devices (AMD) shares slide. AMD fell after the company gave an underwhelming sales outlook, a sign shareholders expected more of a return from the global expansion of AI data centers. Third-quarter revenue will be $13 billion, plus or minus $300 million, according to the chipmaker, though some Wall Street estimates were well north of $13 billion. 
• SpaceX (SPCX) shares fell after the company disclosed higher-than-expected spending on its artificial intelligence business. The company’s capital expenditures soared to $28.5 billion in the first half of the year, with the vast majority of expenditures steered toward AI. SpaceX generated $3.38 billion in revenue from artificial intelligence during the first six months of the year, less than half what its connectivity business brought in during that span. 
• Eli Lilly (LLY) shares jump. Eli Lilly & Co. boosted its 2026 sales guidance after its weight-loss drug franchise performed far better than expected in the second quarter. Sales for the year are forecast to be between $85 billion and $87 billion, with second-quarter adjusted earnings and revenue beating Wall Street estimates.

See omnystudio.com/listener for privacy information.